Mahtaab Hayat

Mahtaab Hayat

Auto-generated profile, based on publicly available information

Mahtaab Hayat

Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MHMahtaab Hayat
Mahtaab Hayat
WCWenlong Chen
Wenlong Chen
CVChantal Babb de Villiers
Chantal Babb de Villiers
SLSang Hyuck Lee
Sang Hyuck Lee
CCCharles Curtis
Charles Curtis
JBJean-Tristan Brandenburg
Jean-Tristan Brandenburg
Genome-wide association studies (GWAS) have characterized the contribution of common variants to breast cancer (BC) risk in populations of European ancestry, however GWAS have not been reported in resident African populations. This GWAS included 2485 resident African BC cases and 1101 population matched controls. Two risk loci were identified, located between UNC13C and RAB27A on chromosome 15 (rs7181788, p = 1.01 × 10−08) and in USP22 on chromosome 17 (rs899342, p = 4.62 × 10−08). Several genome-wide significant signals were also detected in hormone receptor subtype analysis. The novel loci did not replicate in BC GWAS data from populations of West Africa ancestry suggesting genetic heterogeneity in different African populations, but further validation of these findings is needed. A European ancestry derived polygenic risk model for BC explained only 0.79% of variance in our data. Larger studies in pan-African populations are needed to further define the genetic contribution to BC risk.

8 October 2021 in JCO Global Oncology
Verified
Journal Article
Open access
MHMahtaab Hayat
Mahtaab Hayat
WCWenlong Chen
Wenlong Chen
JBJean-Tristan Brandenburg
Jean-Tristan Brandenburg
CVChantal Babb de Villiers
Chantal Babb de Villiers
MRMichèle Ramsay
Michèle Ramsay
CMChristopher G. Mathew
Christopher G. Mathew

21 February 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MHMahtaab Hayat
Mahtaab Hayat
RKRobyn Kerr
Robyn Kerr
ABAmy R. Bentley
Amy R. Bentley
CRCharles N. Rotimi
Charles N. Rotimi
FRFrederick J. Raal
Frederick J. Raal
MRMichèle Ramsay
Michèle Ramsay
Non-communicable diseases, including cardiovascular diseases (CVDs), are increasing in African populations. High serum low density lipoprotein cholesterol (LDL-cholesterol) levels are a known risk factor for CVDs in European populations, but the link remains poorly understood among Africans. This study investigated the associations between serum LDL-cholesterol levels and selected variants in the low density lipoprotein receptor (LDLR), apolipoprotein B (APOB), proprotein convertase subtilisin/kexin type 9 (PCSK9) and low density lipoprotein receptor adaptor protein 1 (LDLRAP1) genes in some selected African populations. Nineteen SNPs were selected from publicly available African whole genome sequence data based on functional prediction and allele frequency. SNPs were genotyped in 1000 participants from the AWI-Gen, study selected from the extremes of LDL-cholesterol level distribution (500 with LDL-cholesterol>3.5 mmol/L and 500 with LDL-cholesterol<1.1 mmol/L). The minor alleles at five of the six associated SNPs were significantly associated (P<0.05) with lower LDL-cholesterol levels: LDLRAP1 rs12071264 (OR 0.56, 95% CI: 0.39–0.75, P = 2.73x10-4) and rs35910270 (OR 0.78, 95% CI: 0.64–0.94, P = 0.008); APOB rs6752026 (OR 0. 55, 95% CI: 0.41–0.72, P = 2.82x10-5); LDLR: rs72568855 (OR 0.47, 95% CI: 0.27–0.82, P = 0.008); and PCSK9 rs45613943 (OR = 0.72, 95% CI: 0.58–0.88, P = 0.001). The minor allele of the sixth variant was associated with higher LDL-cholesterol levels: APOB rs679899 (OR 1.41, 95% CI: 1.06–1.86, P = 0.016). A replication analysis in the Africa America Diabetes Mellitus (AADM) study found the PCSK9 variant to be significantly associated with low LDL-cholesterol levels (Beta = -0.10). Since Africans generally have lower LDL-cholesterol levels, these LDL-cholesterol associated variants may be involved in adaptation due to unique gene-environment interactions. In conclusion, using a limited number of potentially functional variants in four genes, we identified significant associations with lower LDL-cholesterol levels in sub-Saharan Africans.

1 June 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
CMClarisse Musanabaganwa
Clarisse Musanabaganwa
BMBonaventure Mihigo
Bonaventure Mihigo
RTRobert Tumusime
Robert Tumusime
MUMediatrice Uwanyirigira
Mediatrice Uwanyirigira
JRJorge da Rocha
Jorge da Rocha
LMLeon Mutesa
Leon Mutesa
The 11th Congress of the African Society of Human Genetics (AfSHG) was held from September 16, 2018 to September 21, 2018, in conjunction with the 12th Human Heredity and Health in Africa (H3Africa) Consortium meeting in Kigali, Rwanda. The event was organized by the AfSHG in partnership with the Rwanda Society of Human Genetics and the University of Rwanda. A 2-day workshop on the application of next-generation sequencing technologies for analyzing monogenic disease in African populations was organized as part of the conference (September 22, 2018−September 23, 2018, Kigali, Rwanda). The theme of the conference was “Building skills and resources for genomics, epigenetics and bioinformatics research for Africa.” The conference served as a platform to bring together members from country-specific Societies of Human Genetics, including Rwanda, Cameroon, Democratic Republic of Congo, Egypt, Mali, Senegal, and South Africa, and included 435 delegates from 38 countries, including 29 African countries that attended the conference. A major topic of discussion was how to bridge the gap between the emerging knowledge on genomics and Omics in African populations. The importance of understanding the role of genetic variation in disease causation and susceptibility among Africans was a constant theme during the meeting, as was the need to develop research infrastructure and resources to enhance healthcare systems, so that they are not left behind in the genomic revolution. It was concluded that there is a need to inspire more African scientists to train and work as investigators, clinicians, and genetic counselors in the field of human genetics in Africa. Local investments, and South–South and South–North collaboration were identified as the key drivers for the successful implementation of research and development on the continent.

27 May 2020 in F1000Research
Verified
Journal Article
Open access
PDF file
WAWisdom A. Akurugu
Wisdom A. Akurugu
ADAlbert Doughan
Albert Doughan
ABAbdul-Rahman Adamu Bukari
Abdul-Rahman Adamu Bukari
MHMahtaab Hayat
Mahtaab Hayat
ESEmmanuel James San
Emmanuel James San
SSSayane Shome
Sayane Shome
The article elaborates on the program highlights of the 3rd African Student Council Symposium 2019. The one-day symposium was held in Kwame Nkrumah University of Science and Technology (KNUST), Ghana, on 11 November 2019 during the 6th joint international bioinformatics conference of the ISCB and ASBCB. It consisted of three sessions that included keynote talks by Prof Christine Orengo and Dr. Amel Ghouila, and seven selected student speaker talks from different areas of bioinformatics. The students benefited from networking and learning about ongoing research work by their peers hailing from different countries of the African region. The symposium proved to be pivotal to strengthen connections in the African bioinformatics student community.

26 December 2024 in Bioinformatics Advances
Verified
Journal Article
Open access
YSYaniv Swiel
Yaniv Swiel
JBJean-Tristan Brandenburg
Jean-Tristan Brandenburg
MHMahtaab Hayat
Mahtaab Hayat
WCWenlong Chen
Wenlong Chen
MCMitchell A Cox
Mitchell A Cox
SHScott Hazelhurst
Scott Hazelhurst
Summary: Genome-wide association studies (GWASs) analyse genetic variation across many individuals to identify single-nucleotide polymorphisms (SNPs) associated with complex traits. They typically include millions of SNPs from thousands of individuals, creating a multiple testing problem where the probability of false associations increases with the number of SNPs tested. While permutation testing provides accurate control of false positive rates, it is computationally expensive and slow for large datasets. This research presents an FPGA-based tool designed for cloud deployment on AWS EC2 instances that significantly accelerates GWAS permutation testing for continuous phenotypes. The tool implements two algorithms: maxT and adaptive permutation testing. Performance comparisons using a breast cancer dataset (13.7 million SNPs from 3652 individuals) showed large speedups over PLINK running on 40 CPU cores. For 1000 maxT permutations, the FPGA tool completed analysis in 22 min versus PLINK’s 7 days. For 100 million adaptive permutations, FPGA required 325 min compared to PLINK’s 8.5 days. The tool handled 700 million adaptive permutations in 33 h—a workload which would require over a month for CPU-based analysis. FPGA solution provides accessible, order-of-magnitude performance improvements without requiring FPGA expertise or dedicated cluster access.